Low Dose Naltrexone for Fibromyalgia

Links shared publicly online about this topic.

  • 2,030
    total visits

Low Dose Naltrexone for Fibromyalgia

ms.about.com

Low Dose Naltrexone for Fibromyalgia

View full resource at ms.about.com

Tags: Fibromyalgia

  • Share

Most Recently Shared on May 20, 2009 at 1:55 pm By:

GinaSelir Gina Selir

Low Dose Naltrexone for Fibromyalgia - About - News & Issues http://tinyurl.com/q58v6c

3 years ago...

Medical News:Naltrexone May Lessen Chronic Pain - in Meeting Coverage, AAPM from MedPage Today

medpagetoday.com — “Medical News:Naltrexone May Lessen Chronic Pain - in Meeting Coverage, AAPM from MedPage TodayView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on February 26, 2012 at 7:55 pm By:

Low-Dose Naltrexone: The Benefits of This Prescription Drug

articles.mercola.com — “Low-dose naltrexone or LDN, a prescription drug classified as an opioid antagonist, blocks opioid receptors and helps activate your body's immune system.View full resource at articles.mercola.com

  • View Related
  • Share

Most Recently Shared on September 20, 2011 at 1:15 am By:

mercola Dr. Mercola Doctor, Family Medicine Doctor, and Physician

One of the RARE #Drugs that Actually Helps Your Body to Heal Itself. http://ow.ly/6w3Si

7 months ago...

Muscle Relaxant May Ease Fibromyalgia Pain

webmd.com — “Low doses of the muscle relaxant cyclobenzaprine, taken at bedtime, helped those with the painful condition fibromyalgia sleep better and feel less pain, according to a small study.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on September 14, 2011 at 8:03 pm By:

Rheumatology Article | Fibromyalgia

mdlinx.com — “Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: A double-blind randomized placebo-controlled studyView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on September 8, 2011 at 6:59 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patient... http://t.co/r2ujC6l #Rheumatology

7 months ago...

TONIX Pharmaceuticals' Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology - Drugs.com MedNews

drugs.com — “-Phase 2a Study Results Demonstrate Improvement in Core Fibromyalgia Symptoms Including Pain, Tenderness, Fatigue and Depression- -Correlation Between ImprovedView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on September 7, 2011 at 2:04 pm By:

Drugs_Devices Drugs and Devices OW OW Health

TONIX Pharmaceuticals' Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology: -P... http://t.co/NzYE6ev #drug

7 months ago...

Tricking The Body To Heal Itself With Low-Dose Naltrexone (LDN)

medicalnewstoday.com — “Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered the mechanism by which a low dose of the opioid antagonist naltrexone (LDN), an agent usView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 6, 2011 at 8:05 am By:

mnt_cancer MNT Cancer News Health News

Tricking The Body To Heal Itself With Low-Dose Naltrexone (LDN) http://mnt.to/3Zqt #cancer

7 months ago...

Low-dose naltrexone (LDN): Tricking the body to heal itself

sciencedaily.com — “Researchers have discovered the mechanism by which a low dose of the opioid antagonist naltrexone (LDN) can suppress cell proliferative-related disorders such as cancer and autoimmune diseases. LDN causes a compensatory increase in an endogenous opioid, the opioid growth factor (OGF, [Met5]-enkephalin), and the OGF receptor (OGFr).View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on September 3, 2011 at 5:05 pm By:

Low Dose Naltrexone - Tricking Body to Heal Itself

disabled-world.com — “Mechanism by which low dose of the opioid antagonist naltrexone (LDN) an agent used to treat cancer and autoimmune diseases exerts profound inhibitory effect on cell proliferationView full resource at disabled-world.com

  • View Related
  • Share

Most Recently Shared on September 3, 2011 at 10:06 am By:

Low-dose naltrexone (LDN): Tricking the body to heal itself

medicalxpress.com — “Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered the mechanism by which a low dose of the opioid antagonist naltrexone (LDN), an agent used clinically (off-label) to treat cancer and autoimmune diseases, exerts a profound inhibitory effect on ...View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on September 2, 2011 at 7:25 pm By:

physorg_health PhysOrg Health News Health News

Low-dose naltrexone (LDN): Tricking the body to heal itself http://t.co/YMW0yPR

7 months ago...

Harnessing Your Body's Chemistry to Treat Ovarian Cancer

articles.mercola.com — “Low-dose naltrexone (LDN) is an inexpensive prescription treatment that has shown great promise against ovarian cancer and a number of autoimmune diseases.View full resource at articles.mercola.com

  • View Related
  • Share

Most Recently Shared on August 4, 2011 at 11:00 pm By:

mercola Dr. Mercola Doctor, Family Medicine Doctor, and Physician

This breakthrough treatment costs just pennies a day and is showing great promise for #cancer treatment. http://ow.ly/5UQ3o

8 months ago...

LDN Survey for the LDN Aware Week 2011 - "LDN Research Trust" Forum

forum.ldnresearchtrust.org — “Please can you take part in this simply LDN survey, the results will be used anonymously. Once you have taken part in the Survey please click vote ...View full resource at forum.ldnresearchtrust.org

  • View Related
  • Share

Most Recently Shared on August 4, 2011 at 3:45 pm By:

ThyroidMary Mary Shomon, Thyroid Patient Expert

For those interested in Low Dose Naltrexone - LDN Research Trust is asking that: 1. Take part in a survey. The... http://fb.me/1bOgIYlRD

8 months ago...

Low-Dose Naltrexone: Medical Revolution Or Pseudoscience? - Better Health

getbetterhealth.com — “Better Health is a network of healthcare professional blogs, offering commentary on news, research, health policy, healthcare reform, true stories, disease management and expert interviews.View full resource at getbetterhealth.com

  • View Related
  • Share

Most Recently Shared on July 24, 2011 at 8:30 pm By:

Kelly_Young Kelly Young ePatient

RT @westr: @rawarrior R U on LDN? // no, it's not an approved tx for RA or this long list: http://bit.ly/pkxmrM @juleeme @stmprkb #rheum

9 months ago...

Low dose naltrexone (LDN): Harnessing the body's own chemistry to treat human ovarian cancer - http://is.gd/xKp52F

labspaces.net — “Low dose naltrexone (LDN): Harnessing the body's own chemistry to treat human ovarian cancer - http://is.gd/xKp52FView full resource at labspaces.net

  • View Related
  • Share

Most Recently Shared on July 13, 2011 at 3:15 pm By:

LabSpaces Brian Krueger Health News

Low dose naltrexone (LDN): Harnessing the body's own chemistry to treat human ovarian cancer - http://is.gd/xKp52F

9 months ago...

Low dose naltrexone: Harnessing the body's own chemistry to treat human ovarian cancer

sciencedaily.com — “Researchers have discovered that a low dose of the opioid antagonist naltrexone (LDN) markedly suppresses progression of human ovarian cancer transplanted into mice. LDN's antitumor action was comparable to that of chemotherapy (cisplatin, taxol). LDN combined with cisplatin but not taxol had an additive inhibitory action on tumorigenesis. LDN offers a non-toxic and efficacious biologic pathway-related treatment that may benefit patients with this deadly cancer.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on July 13, 2011 at 2:03 pm By:

Low dose naltrexone: Harnessing the body's own chemistry to treat human ovarian cancer

sciencedaily.com — “Researchers have discovered that a low dose of the opioid antagonist naltrexone (LDN) markedly suppresses progression of human ovarian cancer transplanted into mice. LDN's antitumor action was comparable to that of chemotherapy (cisplatin, taxol). LDN combined with cisplatin but not taxol had an additive inhibitory action on tumorigenesis. LDN offers a non-toxic and efficacious biologic pathway-related treatment that may benefit patients with this deadly cancer.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on July 13, 2011 at 2:03 pm By:

Advertisement